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OLTRA eT AL. could inhibit the progression of tumour cells, targeting FOXO1 14 and CBX1, 15 among others, and promotes LRRK2-mediated apoptosis. 16 Enhancement of VEGFA and neovascular overgrowth are behind two associated proliferative retinal disorders: diabetic retinopathy (DR) 17 and the neovascular-aka 'wet' -age-related macular degeneration (AMD). 18, 19 Even though the significant release of VEGF has been reported several times, [20] [21] [22] little is known about the role of miR-205-5p in these diseases. VEGFA is released by retinal cells, including the retinal pigment epithelium (RPE). 23, 24 This layer constitutes the blood-retinal barrier, playing a pivotal role between the bloodstream and photoreceptors. 25 For several reasons (light, metabolic rate, cellular membrane interactions, etc), RPE is continually exposed to oxidative stress (OS) [26] [27] [28] ; hence, OS is considered a relevant risk factor for AMD. [27] [28] [29] Recent reports point out that OS in RPE cells intensifies the production and release of angiogenic factors, thus increasing the formation of new blood vessels. 20, 30, 31 Specifically, OS promotes VEGF production in RPE cells, leading to choroidal neovascularization. 18, 32, 33 In agreement with this, miR-205-5p overexpression also reduced reactive oxygen species (ROS) by increasing peroxiredoxin 2 levels, 34 suggesting that miR-205-5p could be sensitive to oxidative stimuli. Besides, OS is involved in eye diseases, such as AMD, and VEGFA-mediated angiogenesis plays a crucial role in the evolution of these diseases. 27, 29, 35, 36 Indeed, VEGF inhibitors are widely used in both cancer and wet AMD, with beneficial results. 37, 38 The present work focuses on the response of miR-205-5p-VEGFA in ARPE-19 cells to oxidative challenge as an approach to the potential therapeutic target of eye-related proliferative disorders.
| MATERIAL S AND ME THODS

| Cell culture
The ARPE-19 human cell line was obtained from American Type Culture Collection (ATCC). Cells were cultured in Dulbecco's modified Eagle's medium DMEM/F12 (Invitrogen), as previously described. 20 Cells from passage numbers 11-30 were used and cultured to 80%-90% confluence at a starting density of 1 × 10 6 cells/cm 2 on different plates depending on the technique. After 2 days, the cells were treated for 24 hours with 600 µmol/L H 2 O 2 (Scharlau) and 4 mM N-acetylcysteine (NAC) (Sigma-Aldrich) using media with 1% of fetal bovine serum (FBS). Cells and supernatant were collected and preserved for further experiments.
Human umbilical vein endothelial cells (HUVEC) were isolated from umbilical veins as previously described. 39 HUVEC were grown in Endothelial Cell Media supplemented with 20% FBS, penicillin/ streptomycin and amphotericin at 37°C and 5% CO 2 .
| Determination of intracellular ROS
Intracellular ROS levels were measured using dihydroethidium (DHE; Thermo Fisher Scientific), which is a superoxide indicator.
This molecule has a blue fluorescence but, when oxidized to ethidium, it stains DNA red. ARPE-19 cells were seeded at 6 × 10 3 cells/ well in a 96 well plate. Cells were rinsed with PBS (phosphate-buffered saline) twice and incubated with 5 μmol/L DHE for 30 min at 37°C and 5% CO 2 . ROS levels were measured by a fluorescence multiplate reader (Victor X5; Perkin Elmer) excited at 518 nm and read at 605 nm.
| Mimic and inhibitor transfection
ARPE-19 cells seeded in a 6 well plate at 60%-80% confluence were transfected with miR-205-5p mirVana ® miRNA mimic (Thermo 
| RNA isolation and miRNA expression analysis
The RNA was isolated from ARPE-19 cells using the miRNeasy Mini with the appropriate temperature cycles. Normalization was done with GAPDH. Relative expression was calculated as 2 -ΔΔCt .
| Analysis of miRNA target genes
In silico analysis of the putative targets of miR-205-5p was performed using Target Scan Human (http://www.targe tscan.org/ vert_72/). We analysed the pathways regulated by the putative targets of miR-205-5p with FUNRICH using the gene ontology database. With STRING (https ://string-db.org/) we performed the networking of the targets related to angiogenic pathways. 
| Western blotting
| Vasculogenesis assay
Vasculogenesis was analysed in normal Matrigel (Becton Dickinson) as previously described. 39 Briefly, 8 × 10 4 HUVEC cells/well in a 96 well plate were seeded and treated or not with ARPE-19 cells media for 5 hours. The different conditions were determined by the media used; control media, 600 µmol/L H 2 O 2 media, miR-205-5p mimic-transfected control media and miR-205-5p mimictransfected-600 µmol/L H 2 O 2 media from ARPE-19 cells. Matrigel was diluted with DMEM/F12, FBS-free and allowed to solidify overnight at 37°C. Pictures were taken with a CKX41 inverted microscope (Olympus) and images recorded by an DP74 digital camera (Olympus). The images were analysed with Image J using the Angiogenesis Analyzer.
| Statistical analysis
Results of each experiment are presented as mean ± SEM. Statistical significance was set at 0.05 by using t test and 2-way-ANOVA.
| RE SULTS
| Oxidative stress down-regulates miR-205-5p expression
As previously observed, ARPE-19 cells resulted in a significant ROS production after 600 µM H 2 O 2 exposure. 40, 41 This phenomenon was normalized by N-acetylcysteine (NAC) ( Figure 1A) . Significantly reduced miR-205-5p levels were observed in ARPE-19 cells after H 2 O 2 exposure compared with control cells ( Figure 1B) . In order to assess whether this increase is oxidative stress-dependent, the antioxidant NAC (4 mmol/L) was added. NAC normalized the miR-205-5p levels reduced by H 2 O 2 . No significant changes in miR-205-5p expression levels were found in control ARPE-19 cells after NAC exposure ( Figure 1B ). Figure 2A . After selecting angiogenic and vasculogenic related processes, 32 mRNA predicted targets were found according to their functional protein association network, using STRING (https ://string-db.org/) ( Figure 2B and File S1).
| miR-205-5p targets are related to vascular processes
| VEGFA mRNA is a direct target of miR-205-5p
Consistently with previous results, in silico analysis showed that VEGFA mRNA is a predicted target for miR-205-5p ( Figure 2B) . Target Scan predicted a 3'-UTR binding site for VEGFA mRNA and miR-205-5p ( Figure 3A) . In order to confirm the relation between VEGFA mRNA and miR-205-5p, VEGFA mRNA expression was analysed after H 2 O 2 treatment. We observed that VEGFA mRNA levels were up-regulated after H 2 O 2 exposure ( Figure 3C ), indicating a negative correlation with miR-205-5p levels ( Figure 3B and 3D) .
Matching with the aforementioned results on miR-205-5p levels, VEGFA mRNA levels were also normalized by NAC exposure ( Figure 3E ).
| VEGFA expression is regulated by miR-205-5p
In order to test the role of miR-205-5p on VEGFA mRNA expression, ARPE-19 cells were transfected with a miR-205-5p mimic.
The transfection process did not affect the ARPE-19 cells viability (File S2). The transfection with a negative control did not affect miR-205-5p expression. Transfected ARPE-19 cells with the mimic, increased miR-205-5p levels ( Figure 4A ), decreasing VEGFA mRNA levels ( Figure 4B) . Similarly, transfected ARPE-19 cells also decreased VEGFA mRNA levels after H 2 O 2 exposure ( Figure 4B) . These results were confirmed by Western blotting analysis, showing a significant decrease of VEGFA protein expression after miR-205-5p mimic transfection in H 2 O 2 treated cells ( Figure 4C ).
MiR-205-5p was inhibited in untreated ARPE-19 cells and expression of mRNA VEGFA studied. No significant changes were found (File S3). 
| Vasculogenesis is affected by miR-205-5p deregulation via VEGFA
Interestingly, HUVEC cells grown with mimic-transfected ARPE-19
cell culture media significantly abolished these angiogenic changes ( Figure 5D , 5E and 5F). Cell culture media from mimic-transfected ARPE-19 cells also reduced angiogenesis in control HUVEC cells ( Figure 5B, 5E and 5F ).
F I G U R E 4 VEGFA expression is regulated by miR-205-5p. MiR-205-5p expression levels after 48 h of miR-205-5p mimic transfection and mimic negative control (A). VEGFA mRNA expression levels after 48 h of transfection with miR-205-5p mimic and mimic negative control were measured by qRT-PCR (B). Western blot analysis for VEGFA protein after miR-205-5p mimic and mimic negative control transfection (C). Values are expressed as mean ± SEM (n = 3). Statistically significant differences were set at *P < .05, **P < .01, ***P < .001 and ****P < .0001
| D ISCUSS I ON
In a previous report, in which miR-205-5p was mapped in the mammalian eye, it was found in the epidermis and the anterior segmental epithelia and was not found in RPE. 42 Other studies have found that miR-125b 43 and miR-23a 44 are overexpressed in oxidative stressinduced RPE cells. 41 This current report is the first one indicating the presence of miR-205-5p in ARPE-19 cells as an RPE cell type. In contrast to the relevance of this miRNA on glioblastoma 13 or hepatocellular carcinoma, 45 little information is available about the presence of miR-205-5p in the eye.
| Oxidative stress down-regulates miR-205-5p expression
As mentioned above, H 2 O 2 exposure resulted in a significant decrease in miR-205-5p levels in ARPE-19 cells. It has been suggested that miR-205-5p positively regulates the peroxiredoxin 2 (PRDX2) pathway. 34 PRDX2 reduces ROS derived from H 2 O 2 transformation.
In addition, miR-205-5p was identified as protective against OS via EGLN2 suppression. 46 Once considering this, reducing miR-205-5p levels after oxidative challenge is opposed to this proposed antioxidant mechanism. Perhaps excessive OS challenge (24 hours H 2 O 2 600 µmol/L) leads to a different scenario, far from the physiological conditions that occur in wet AMD or cancer. Future research must address the antioxidant role of miR-205-5p. Another relevant finding is that NAC normalized those decreased miR-205-5p levels, indicating that miR-205-5p is sensitive to ROS.
| VEGFA mRNA as a miR-205-5p target
According to Yue et al., VEGFA 3'UTR-mRNA is one of the putative targets of miR-205-5p. 7 In addition, we have identified some potential targets of miR-205-5p and their biological processes. Among the potential mRNAs regulated by miR-205-5p, 3.5% are angiogenic and 1.3% are related to endothelial cell migration ( Figure 2 ). In fact, it F I G U R E 5 VEGFA-mediated Vasculogenesis is regulated by miR-205-5p. HUVEC cell tube formation under different ARPE-19 cell culture media conditions. ARPE-19 control medium (A), mimic(miR-205-5p)-treated ARPE-19 control (B), H 2 O 2 600 µmol/L treated ARPE-19 (C) and mimic-treated ARPE-19 + H 2 O 2 600 µmol/L medium (D). Scale bar 100 µmol/L. Total branch length (E) and total length (F) were calculated. Values are expressed as mean ± SEM (n = 3). Statistically significant differences were set at *P < .05 is well documented that miR-205-5p acts as a tumour suppressor by regulating cell migration and proliferation. 7, [11] [12] [13] 47 Moreover, it has been suggested that miR-205-5p could interact indirectly via PI3K/AKT also involved in angiogenesis. 13 In the present report, we have observed that VEGFA and miR-205-5p are inversely expressed ( Figure 3) , inducing angiogenesis.
The results shown here confirm the fact that OS increases VEGFA expression levels. 20 NAC is a precursor of l-cysteine with scavenging properties and antioxidant effects, interacting with the antioxidant glutathione system. 50, 51 In addition to direct VEGFA regulation, miR-205-5p also indirectly regulates ERK1/2 and PI3K/AKT pathways. 13, 52 The Anti-VEGF administration is currently used to control neovascular processes in both DR and wet AMD. 37 Similarly, anti-VEGF therapies are also helpful against different forms of cancer, such as glioblastoma and colorectal cancer. 55 In agreement with this, miR-205-5p suppresses VEGFA expression in glioblastoma 7 and also inhibits the PI3K/AKT pathway. 13 In accordance with this, reducing VEGF-angiogenesis and PI3K/AKT could decrease tumour cell viability and proliferation. Thus, miR-205-5p could be considered as a plausible target against local vascular proliferative retinal processes.
Moreover, increasing miR205-5p levels could be beneficial for these ocular proliferative disorders not only by the direct anti-VEGFA blockade but also by the PI3K/AKT pathway interaction.
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